Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Chinese investigators identify new TGFBR1 inhibitors

March 9, 2021

Artios Pharma divulges POLQ inhibitors

March 9, 2021

Idorsia Pharmaceuticals patents LGALS3 inhibitors

March 9, 2021

Collagen means well in pancreatic cancer

March 9, 2021

Chimerix opens enrollment in phase III study of dociparstat for AML

March 9, 2021

Incyte discloses CDK2/cyclin E inhibitors

March 8, 2021

BiSiChem identifies RIPK1 inhibitors

March 8, 2021

Taiho begins phase II study of TAS-117 in advanced solid tumors with germline PTEN mutations

March 8, 2021

Post-chemo bone marrow regeneration elucidated

March 8, 2021

CYH-33 demonstrates preliminary antitumor activity in PIK3CA-mutant tumors

March 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...